Breye Therapeutics develops novel, orally administered ophthalmology drugs to meet the needs of patients suffering vision loss. The company addresses the unmet medical need for more effective therapies.
peer of
competitor of
Metrics
marketPRIVATE
msh_idCOM:BREYE
localedk
websitehttps://breye.com/
source_ref83d73068-49fc-4eb4-b925-1a4b9efff039
products_or_servicesNovel oral ophthalmology drugs, primarily focused on treating vision loss.
Denmark